Physician

Mohit Nanda, MD

According to 2025 Medicare claims, Mohit Nanda, MD (NPI: 1750363396) practices ophthalmology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is VIRGINIA RETINA CONSULTANTS, PLC (NPI: 1700976834; TIN: 030549949) and primary practice location at 22911-8836.

Nanda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,238 traditional Medicare patients, billed 80,332 HCPCS/CPT codes, and received $4,435,062 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 236 prescription claims across 104 beneficiaries totaling $44,955 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $24,401 and ending at $44,955. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $4,059,628 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,921,142 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,814,800 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,086,281 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,233,094 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,196,628 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,990,343 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,259,904 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,617,106 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,435,062 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,23622,383$4,059,628
20161,28822,179$3,921,142
20171,25719,859$3,814,800
20181,31120,255$4,086,281
20191,43820,866$4,233,094
20201,32217,643$4,196,628
20211,31217,026$3,990,343
20221,39119,770$4,259,904
20231,33746,141$4,617,106
20241,23880,332$4,435,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$45K2015 Drug cost: $24,401 (USD; Tot_Drug_Cst)2016 Drug cost: $23,990 (USD; Tot_Drug_Cst)2017 Drug cost: $26,765 (USD; Tot_Drug_Cst)2018 Drug cost: $24,643 (USD; Tot_Drug_Cst)2019 Drug cost: $39,391 (USD; Tot_Drug_Cst)2020 Drug cost: $34,905 (USD; Tot_Drug_Cst)2021 Drug cost: $18,408 (USD; Tot_Drug_Cst)2022 Drug cost: $23,890 (USD; Tot_Drug_Cst)2023 Drug cost: $10,930 (USD; Tot_Drug_Cst)2024 Drug cost: $44,955 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585279$24,401
2016107337$23,990
2017122384$26,765
2018110316$24,643
2019133389$39,391
2020108345$34,905
2021107256$18,408
2022118269$23,890
2023103231$10,930
2024104236$44,955

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system7911,191$87
67028Injection of drug into eye4452,456$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4201,060$63
92134Imaging of retina1,1343,511$28
92202Extended exam of the back part of the eye with optic nerve drawing1,1332,402$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate742,102$1,721
LatanoprostLatanoprost744,786$799
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat342,372$625

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$170Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohit Nanda, MD?

Tedicare shows public-source Medicare data for Mohit Nanda, MD (NPI 1750363396), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohit Nanda, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohit Nanda, MD?

Mohit Nanda, MD is linked to VIRGINIA RETINA CONSULTANTS, PLC (billing NPI 1700976834) in the available physician profile data.

Does Mohit Nanda, MD have Open Payments data?

Mohit Nanda, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.